D-0831-2022 Class II Terminated

Recalled by SCA Pharmaceuticals — Windsor, CT

FDA drug recall D-0831-2022 was initiated by SCA Pharmaceuticals on Apr 25, 2022 and is designated Class II. Reason for recall: CGMP Deviations The recall status is terminated (terminated Sep 9, 2022). Affected quantity: 30 bags.

Recall Details

Product Type
Drugs
Report Date
May 11, 2022
Initiation Date
Apr 25, 2022
Termination Date
Sep 9, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
30 bags

Product Description

Vancomycin HCl 1.5 g in 0.9% Sodium Chloride, 500 mL bags, Rx only, SCA Pharmaceuticals Windsor, CT 06095, NDC 70004-0924-44

Reason for Recall

CGMP Deviations

Distribution Pattern

Product was distributed nationwide within the United States

Code Information

Lot #: 1222035839, Exp. Date 09-Aug-22

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0831-2022
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 25, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.